Browse Related Topics For:

ANDA

317
Pharmaceutical Industry
315
Patents
279
Pharmaceutical Patents
255
Patent Infringement
253
Generic Drugs
250
Patent Litigation
158
FDA
151
Hatch-Waxman
148
Prescription Drugs
69
Patent-in-Suit
52
Mylan Pharmaceuticals
45
Teva Pharmaceuticals
42
Actavis Inc.
39
FTC
38
Obviousness
38
Reverse Payment Settlement Agreements
38
SCOTUS
36
Intellectual Property Protection
32
Biotechnology
32
FTC v Actavis
31
Patent Invalidity
29
Personal Jurisdiction
26
Apotex
25
Merck
23
Appeals
23
Prior Art
22
Claim Construction
21
AstraZeneca
21
Sandoz
20
Watson Pharmaceuticals
18
Eli Lilly
18
Orange Book
17
On-Sale Bar
16
Antitrust Litigation
16
Infringement
16
Pay-For-Delay
15
Motion to Dismiss
14
America Invents Act
14
FDA Approval
14
FDCA
14
Noninfringement
14
Novartis
14
Patent Trial and Appeal Board
13
Allergan Inc
13
BPCIA
13
Declaratory Judgments
13
Inter Partes Review (IPR) Proceeding
12
Induced Infringement
12
Manufacturers
12
Popular
12
Sherman Act
12
USPTO
11
Biosimilars
11
Cephalon
11
Hospira
11
Jurisdiction
11
Labeling
11
Par Pharmaceutical
11
Patent Applications
11
Pfizer
10
Corporate Counsel
10
Roxane Laboratories
10
Summary Judgment
9
Bayer
9
DaimlerChrysler v Bauman
9
Healthcare
8
Amgen
8
Drug Pricing
8
GlaxoSmithKline
8
Medical Devices
8
Safe Harbors
8
Specific Jurisdiction
7
Anti-Competitive
7
Antitrust Violations
7
Biologics
7
Endo Pharmaceuticals
7
Generic
7
Janssen Pharmaceuticals
7
Product Labels
6
AbbVie
6
Class Action
6
Commercial Marketing
6
DaimlerAG
6
Doctrine of Equivalents
6
Federal Rule 12(b)(6)
6
Gilead Sciences
6
Life Sciences
6
Method Claims
6
Minimum Contacts
6
Orphan Drugs
6
Patent-Eligible Subject Matter
6
Product Exclusivity
6
Prometheus
6
Reversal
6
Settlement
6
Standing
6
Warner Chilcott
6
Written Descriptions
5
Antitrust Provisions
5
Exclusivity
5
Medicare
5
Otsuka Pharmaceutical
5
REMS
5
Rule-of-Reason Analysis
5
Subject Matter Jurisdiction
5
Trump Administration
4
Boehringer
4
Bristol-Myers Squibb
4
CAFC
4
Direct Infringement
4
Forest Laboratories
4
General Jurisdiction
4
HHS
4
Legislative Agendas
4
Medicare Modernization Act
4
No-AG Agreement
4
Permanent Injunctions
4
Physicians
4
Product Hopping
4
Spectrum
4
Suppliers
4
Takeda Pharmaceuticals
4
TC Heartland LLC v Kraft Foods
3
Affordable Care Act
3
Allergan v Sandoz
3
Amarin
3
Article III
3
Burden of Proof
3
Citizen Petitions
3
Classen Immunotherapies
3
CLS Bank v Alice Corp
3
CMS
3
Counterclaims
3
Disgorgement
3
Elan Pharmaceuticals
3
Enablement Inquiries
3
Estoppel
3
Failure To Warn
3
Federal Rules of Civil Procedure
3
Forum Shopping
3
Fresenius
3
Genzyme
3
Intellectual Property Litigation
3
Jazz Pharmaceuticals
3
Limelight v Akamai
3
Markman Hearing
3
Medicaid
3
Medicare Prescription Drug Improvement and Modernization Act (MMA)
3
Mergers
3
Patent Dance
3
Patients
3
Preliminary Injunctions
3
Principal Place of Business
3
RanBaxy
3
Real Party in Interest
3
Reverse Payments
3
Sandoz v Amgen
3
Shire Development v Watson
3
SmithKline Beecham
3
Third-Party Relationships
3
Unfair Competition
3
Venue
2
aBLA
2
Antitrust Investigations
2
Aurobindo Pharmaceuticals
2
Bausch & Lomb
2
Biopharmaceutical
2
Brand
2
Cadence Pharmaceuticals Inc.
2
Cadillac Tax
2
Cancer
2
Chevron Deference
2
Clinical Trials
2
Competition
2
De Novo Standard of Review
2
Disclosure Requirements
2
Discovery
2
Dismissals
2
Divided Infringement
2
Draft Guidance
2
En Banc Review
2
Extortion
2
FDARA
2
FDASIA
2
Federal Budget
2
Federal Rule 12(b)(1)
2
Forum
2
Forum Selection
2
GDUFA
2
Health Care Providers
2
Health Insurance
2
Indefiniteness
2
Injunctions
2
Inter Partes Reexamination
2
Interlocutory Appeals
2
Inventors
2
Investigational New Drug Application (IND)
2
IRS
2
ITC
2
Judge Stark
2
Laches
2
Lanham Act
2
Malicious Prosecution
2
Monopolization
2
Motion To Stay
2
Notice Requirements
2
Nunc Pro Tunc
2
OIG
2
Out-of-State Companies
2
OxyContin
2
Pleading Standards
2
Pleadings
2
PLIVA v Mensing
2
Preemption
2
Proposed Legislation
2
Public Health Service Act
2
Putative Class Actions
2
Rebates
2
Reissue Patents
2
Remand
2
Reporting Requirements
2
Rulemaking Process
2
Sanofi
2
Sanofi-Aventis
2
Trademarks
2
Treatment Method Patents
2
TRO
2
User Fees
2
Vaccinations
1
Abbott Laboratories
1
Abstract Ideas
1
Abuse of Discretion
1
ACOs
1
Acquisitions
1
Administrative Procedure Act
1
Administrative Proceedings
1
Advertising
1
Affirmative Defenses
1
AHRQ
1
Akamai Technologies
1
Amazon
1
Ambiguous
1
Anti-SLAPP
1
Anti-Steering Rules
1
Antibiotics
1
Anticompetitive Behavior
1
Antitrust Conspiracies
1
Antitrust Division
1
Antitrust Injuries
1
App Developers
1
Arbitration
1
Arbitration Agreements
1
Artificial Intelligence
1
Assignments
1
Assignor Estoppel
1
Attorney-Client Privilege
1
Automatic Stay
1
Bifurcation
1
Big Data
1
Bipolar Disorder
1
CA Supreme Court
1
Cal Code of Civil Procedure
1
Carve Out Provisions
1
Causation
1
CDC
1
Certification Requirements
1
Certifications
1
Certiorari
1
CGMP
1
CHIP
1
Cipro
1
Cisco v CommilUSA
1
Civil Monetary Penalty
1
Claim Preclusion
1
Claims Limitations Period
1
Class Certification
1
Classification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
CLIA
1
Clinical Laboratory Testing
1
Collateral Estoppel
1
Combination Products
1
Comment Period
1
Complex Litigation
1
Compliance
1
Confidentiality Agreements
1
Consent
1
Consent Order
1
Continuing Resolution
1
Contract Disputes
1
Contract Drafting
1
Copyright
1
Copyright Infringement
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
Damages
1
Debt Ceiling
1
Delaware General Corporation Law
1
Dell
1
Denial of Certiorari
1
Depositions
1
Direct Purchasers
1
Disclosure
1
Divestiture
1
DMCA
1
DOJ
1
Drug Design
1
DSCSA
1
Due Process
1
Duty to Deal
1
E-Filing
1
Employer Mandates
1
Enforcement Actions
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Failure To State A Claim
1
Fair Market Value
1
Fair Use
1
False Advertising
1
False Claims Act (FCA)
1
FD&C Act
1
Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015
1
Federal Jurisdiction
1
Final Written Decisions
1
First Amendment
1
Food and Drug Administration Amendments Act (FDAAA)
1
Foreign Corporations
1
Foreign Defendants
1
Forum Non Conveniens
1
Funding
1
Genentech
1
Good Faith
1
Goodyear
1
Government Investigations
1
Guidance Update
1
Hart-Scott-Rodino Act
1
Hedge Funds
1
HIV
1
Hoffman LaRoche
1
Home Healthcare Workers
1
Hospital Mergers
1
HRSA
1
Imminent Harm
1
Implied Consent
1
Indirect Infringement
1
Individual Mandate
1
Inducement
1
Information Reports
1
Innovation
1
Innovation Act
1
Integra
1
International Arbitration
1
Internet of Things
1
IP Assignment Agreements
1
Issue Preclusion
1
John Boehner
1
Joint Venture
1
Judgment on the Pleadings
1
Justiciable Controversy
1
Leave to Amend
1
Lenz v Universal Music Corp.
1
License Agreements
1
Licensing Rules
1
Likelihood of Success
1
Lipitor
1
Litigation Privilege
1
Long Arm Statute
1
Luxembourg
1
Manufacturing Facilities
1
Marketing
1
Martin Shkreli
1
Mayo v. Prometheus
1
MDRP
1
Meaningful Use
1
Means-Plus-Function
1
Medicaid Expansion
1
Medical Device Tax
1
Medical Foods
1
Medical Research
1
Mensing
1
Minimum Wage
1
Misbranding
1
Mootness
1
Motion for Reconsideration
1
Motion to Amend
1
Motion to Transfer
1
Mylan Pharmaceuticals Inc v Acorda Theraputics Inc
1
New Guidance
1
New Legislation
1
New Trial
1
Nexium
1
NIH
1
Nintendo
1
Noerr-Pennington Doctrine
1
Nominations
1
Non-Compete Agreements
1
Non-Disclosure Agreement
1
Obama Administration
1
Off-Label Promotion
1
Off-Label Use
1
Offsets
1
Opioid
1
OTDP
1
Overpayment
1
Partial Summary Judgments
1
PATENT Act
1
Patent Agent Privilege
1
Patent Ownership
1
Patent Prosecution
1
Patent Reform
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent Trolls
1
Patent Validity
1
Patent-Misuse
1
PDUFA
1
Pediatrics
1
Pending Legislation
1
Personalized Medicine
1
Petition For Rehearing
1
Petition for Writ of Certiorari
1
Pharmacies
1
Physical Presence Test
1
Physician Medicare Reimbursements
1
Physician SGR Formula
1
Physician-Assisted Suicide
1
Post-Grant Review
1
Post-Market Approval
1
Premerger Notifications
1
Presumption of Validity
1
Prince
1
Proposed Regulation
1
Proposed Rules
1
Public Disclosure
1
Public Health Insurance Marketplace
1
Public Interest
1
Public Meetings
1
Purchase Agreement
1
Qui Tam
1
Registration Requirement
1
Regulatory Oversight
1
Regulatory Standards
1
Research and Development
1
Research Tools
1
Restraining Orders
1
Restrictive Covenants
1
Royalties
1
Sales Contracts
1
Sanctions
1
SCA Hygiene Products Aktiebolag v First Quality Baby Products
1
SEC
1
Secretary of HHS
1
Section 102
1
Section 337
1
Section 340B
1
Set-Asides
1
Settlement Agreements
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
SNDAs
1
Social Services
1
Software Patents
1
Sovereign Immunity
1
Split of Authority
1
Standard Essential Patents
1
Standard of Proof
1
Standard of Review
1
Startups
1
State Law Tort Claims
1
State of Incorporation
1
Statutory Authority
1
Subsidiaries
1
Substantial Evidence Standard
1
Takedown Notices
1
Tax Liability
1
The Common Rule
1
The Patent Act
1
Threshold Requirements
1
Tolling
1
Totality of Circumstances Test
1
Trade Secrets
1
Trademark Infringement
1
Trans-Pacific Partnership
1
Transfer of Title
1
Transfer of Venue
1
Tyco
1
Unclean Hands
1
Universal Health Services Inc v United States ex rel Escobar
1
Vacated
1
Valeant
1
Validity
1
Wage and Hour
1
WIPO
1
Work Product Privilege
1
Wyeth
1
Young Lawyers
1
YouTube